Compare OPK & FSSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | FSSL |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 906.5M |
| IPO Year | 2011 | 2025 |
| Metric | OPK | FSSL |
|---|---|---|
| Price | $1.66 | $11.78 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.60 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 213.9K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | ★ N/A | $9.70 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $10.75 |
| 52 Week High | $1.73 | $14.49 |
| Indicator | OPK | FSSL |
|---|---|---|
| Relative Strength Index (RSI) | 63.98 | 54.17 |
| Support Level | $1.12 | $11.16 |
| Resistance Level | $1.73 | $11.88 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 72.73 | 55.93 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing mainly in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest mainly in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.